Phage display for the production of human monoclonal antibodies against human pathogens

New Microbiologica

Volumn 27, Issue 4, 2004, Pages 315-328

  Mancini, N ^a   Carletti, S ^a   Perotti, M ^a   Canducci, F ^a   Mammarella, M ^a   Sampaolo, M ^a   Burioni, R ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Host pathogen interplay; Human monoclonal antibodies; Monovalent Fab; Phage display; Single chain Fv fragment (scfv)

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS ANTIBODY;

ANTIBIOTIC RESISTANCE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; HOST RESISTANCE; HUMAN; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; REVIEW;

ANTIBODIES, MONOCLONAL; BACTERIOPHAGES; BIOTECHNOLOGY; HUMANS; PEPTIDE LIBRARY;

EID: 12144277087     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. AMERSDORFER P., WONG C., SMITH T., CHEN S., DESHPANDE S., SHERIDAN R. AND MARKS J. D. (2002). Genetic and immunological comparison of antibotulinum type A antibodies from immune and non-immune human phage libraries. Vaccine, 20, 1640-8.
2. ANDREAKOS E., TAYLOR P. C. AND FELDMANN M. (2002). Monoclonal antibodies in immune and inflammatory diseases. Current Opinion in Biotechnology, 13, 615-20.
3. AUJAME L., GEOFFROY F. AND SODOYER R. (1997). High affinity human antibodies by phage display. Human Antibodies, 8, 155-68.
4. BAEK H., SUK K. H., KIM Y. H. AND CHA S. (2002). An improved helper phage system for efficient isolation of specific antibody molecules in phage display. Nucleic Acids Research, 30, e18.
5. BAERT F., NOMAN M., VERMEIRE S., VAN ASSCHE G., G D. H., CARBONEZ A. AND RUTGEERTS P. (2003). Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. The New England Journal of Medicine, 348, 601-8.
6. BARBAS C. F., 3RD, KANG A. S., LERNER R. A. AND BENKOVIC S. J. (1991). Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proceedings of the National Academy of Sciences of the USA, 88, 7978-82.
7. BARBAS III C. F., BURTON D. R., SCOTT J. K. AND SILVERMAN G. J. (2001). Appendix 1: Useful Information. In: Phage Display: A Laboratory Manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press.
8. BATRA S. K., JAIN M., WITTEL U. A., CHAUHAN S. C. AND COLCHER D. (2002). Pharmacokinetics and biodistribution of genetically engineered antibodies. Current Opinion in Biotechnology, 13, 603-8.
9. BERGER M., SHANKAR V. AND VAFAI A. (2002). Therapeutic applications of monoclonal antibodies. American Journal of Medical Sciences, 324, 14-30.
10. BRADBURY A. R. AND MARKS J. D. (2004). Antibodies from phage antibody libraries. Journal of Immunological Methods, 290, 29-49.
11. BREITLING F., DUBEL S., SEEHAUS T., KLEWINGHAUS I. AND LITTLE M. (1991). A surface expression vector for antibody screening. Gene, 104, 147-53.
12. BUGLI F., BASTIDAS R., BURTON D. R., WILLIAMSON R. A., CLEMENTI M. AND BURIONI R. (2001a). Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen. Human Immunology, 62, 362-7.
13. BUGLI F., MANCINI N., KANG C. Y., DI CAMPLI C., GRIECO A., MANZIN A., GABRIELLI A., GASBARRINI A., FADDA G., VARALDO P. E., CLEMENTI M. AND BURIONI R. (2001b). Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. Journal of Virology, 75, 9986-90.
14. BURIONI R., WILLIAMSON R. A., SANNA P. P., BLOOM F. E. AND BURTON D. R. (1994). Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proceedings of the National Academy of Sciences of the USA, 91, 355-9.
15. BURIONI R., PLAISANT P., RICCIO M. L., ROSSOLINI G. M., SANTANGELO R., VANNINI A. AND SATTA G. (1995a). Engineering human monoclonal antibody fragments: a recombinant enzyme- linked Fab. Microbiologica, 18, 127-33.
16. BURIONI R., PLAISANT P., RICCIO M. L., ROSSOLINI G. M. AND SATTA G. (1995b). A new plasmid cloning vector for direct detection of recombinant clones, based on inactivation of a bacterial acid phosphatase-encoding gene. Microbiologica, 18, 201-6.
17. BURIONI R., PLAISANT P., DELLI CARRI V., VANNINI A., SPANU T., CLEMENTI M., FADDA G. AND VARALDO P. E. (1997). An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries. Research in Virology, 148, 161-4.
18. BURIONI R., PLAISANT P., BUGLI F., DELLI CARRI V., CANDELA M., GABRIELLI A. AND FADDA G. (1998a). Probing the natural antibody repertoire by combinatorial cloning of IgM and IgD isotypes in phage display vectors. Research in Virology, 149, 321-5.
19. BURIONI R., PLAISANT P., BUGLI F., DELLI CARRI V., CLEMENTI M. AND FADDA G. (1998b). A vector for the expression of recombinant monoclonal Fab fragments in bacteria. Journal of Immunological Methods, 217, 195-9.
20. BURIONI R., PLAISANT P., BUGLI F., SOLFOROSI L., DELLI CARRI V., VARALDO P. E. AND FADDA G. (1998c). A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries. Research in Virology, 149, 327-30.
21. BURIONI R., PLAISANT P., MANZIN A., ROSA D., DELLI CARRI V., BUGLI F., SOLFOROSI L., ABRIGNANI S., VARALDO P. E., FADDA G. AND CLEMENTI M. (1998d). Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology, 28, 810-4.
22. BURIONI R. (2000). Blocking immunodominant epitopes by competitive deselection. In: Antibody phage display: methods and protocols. Totowa, NJ, USA, Humana Press.
23. BURIONI R., BUGLI F., MANCINI N. AND FADDA G. (2001a). A novel expression vector for production of epitope-tagged recombinant Fab fragments in bacteria. Human Antibodies, 10, 149-154.
24. BURIONI R., BUGLI F., MANCINI N., ROSA D., Di CAMPLI C., MORONCINI G., MANZIN A., ABRIGNANI S., VARALDO P. E., CLEMENTI M. AND FADDA G. (2001b). Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology, 288, 29-35.
25. BURIONI R., MATSUURA Y., MANCINI N., TANI H., MIYAMURA T., VARALDO P. E. AND CLEMENTI M. (2002). Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype. Journal of Virology, 76, 11775-9.
26. BURIONI R., MANCINI N., CANDUCCI F., CARLETTI S., GRIECO A., PEROTTI M., SERAFINI G., BERARDINELLI E., BIGHI S., VARALDO P. E. AND CLEMENTI M. (2003). Humoral immune response against hepatitis C virus. Journal of Biological Regulators and Homeostatic Agents, 17, 125-7.
27. BURIONI R., MANCINI N., CARLETTI S., PEROTTI M., GRIECO A., CANDUCCI F., VARALDO P. E. AND CLEMENTI M. (2004). Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. Virology, 327, 242-8.
28. BURTON D. R., BARBAS C. F. D., PERSSON M. A., KOENIG S., CHANOCK R. M. AND LERNER R. A. (1991). A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proceedings of the National Academy of Sciences of the USA, 88, 10134-7.
29. BURTON D. R. (1997). A vaccine for HIV type 1: the antibody perspective. Proceedings of the National Academy of Sciences of the USA, 94, 10018-23.
30. BURTON D. R. AND MONTEFIORI D. C. (1997). The antibody response in HIV-1 infection. AIDS, 11, S87-98.
31. BURTON D. R. AND PARREN P. W. H. I. (2000). Vaccine and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nature Medicine, 6, 123-125.
32. BURTON D. R. (2002). Antibodies, viruses and vaccines. Nature Reviews Immunology, 2, 706-13.
33. CHANG T. Y. AND SIEGEL D. L. (2001). Isolation of an IgG anti-B from a human Fab-phage display library. Transfusion, 41, 6-12.
34. CLACKSON T., HOOGENBOOM H. R., GRIFFITHS A. D. AND WINTER G. (1991). Making antibody fragments using phage display libraries. Nature, 352, 624-8.
35. CLARK M. A., HAWKINS N. J., PAPAIOANNOU A., FIDDES R. J. AND WARD R. L. (1997). Isolation of human anti-c-erbB-2 Fabs from a lymph node-derived phage display library. Clinical and Experimental Immunology, 109, 166-74.
36. CWIRLA S. E., PETERS E. A., BARRETT R. W. AND DOWER W. J. (1990). Peptides on phage: a vast library of peptides for identifying ligands. Proceedings of the National Academy of Sciences of the USA, 87, 6378-82.
37. DAUGHERTY P. S., CHEN G., IVERSON B. L. AND GEORGIOU G. (2000). Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proceedings of the National Academy of Sciences of the U S A, 97, 2029-34.
38. DE CARVALHO NICACIO C., WILLIAMSON R. A., PARREN P. W., LUNDKVIST A., BURTON D. R. AND BJORLING E. (2002). Neutralizing human Fab fragments against measles virus recovered by phage display. Journal of Virology, 76, 251-8.
39. DE HAARD H. J., VAN NEER N., REURS A., HUFTON S. E., ROOVERS R. C., HENDERIKX P., DE BRUINE A. P., ARENDS J. W. AND HOOGENBOOM H. R. (1999). A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. Journal of Biological Chemistry, 274, 18218-30.
40. DEL RINCON I., ZEIDEL M., REY E., HARLEY J. B., JAMES J. A., FISCHBACH M. AND SANZ I. (2000). Delineation of the human systemic lupus erythematosus anti-Smith antibody response using phage-display combinatorial libraries. Journal of Immunology, 165, 7011-6.
41. DEN W., SOMPURAM S. R., SARANTOPOULOS S. AND SHARON J. (1999). A bidirectional phage display vector for the selection and mass transfer of polyclonal antibody libraries. Journal of Immunological Methods, 222, 45-57.
42. DENG S. J., MACKENZIE C. R., SADOWSKA J., MICHNIEWICZ J., YOUNG N. M., BUNDLE D. R. AND NARANG S. A. (1994). Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display. Journal of Biological Chemistry, 269, 9533-8.
43. DITZEL H. J., MASAKI Y., NIELSEN H., FARNAES L. AND BURTON D. R. (2000). Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome. Proceedings of the National Academy of Sciences of the USA, 97, 9234-9.
44. DUENAS M. AND BORREBAECK C. A. (1995). Novel helper phage design: intergenic region affects the assembly of bacteriophages and the size of antibody libraries. FEMS Microbiology Letters 125 317-21.
45. EHRLICH P. (1900). On immunity: with special reference to cell life. Proceedings of the Royal Society of London, 66.
46. EMADI S., LIU R., YUAN B., SCHULZ P., MCALLISTER C., LYUBCHENKO Y., MESSER A. AND SIERKS M. R. (2004). Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry, 43, 2871-8.
47. ENDEMANN H. AND MODEL P. (1995). Location of filamentous phage minor coat proteins in phage and in infected cells. Journal of Molecular Biology, 250, 496-506.
48. EVAN G. I., LEWIS G. K., RAMSAY G. AND BISHOP J. M. (1985). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Molecular and Cellular Biology, 5, 3610-6.
49. FERMER C., ANDERSSON I., NILSSON K. AND NILSSON O. (2004). Specificity rescue and affinity maturation of a low-affinity IgM antibody against pro-gastrin-releasing peptide using phage display and DNA shuffling. Tumor Biology, 25, 7-13.
50. GARRARD L. J., YANG M., O'CONNELL M. P., KELLEY R. F. AND HENNER D. J. (1991). Fab assembly and enrichment in a monovalent phage display system. Biotechnology (N Y), 9, 1373-7.
51. GRAM H., MARCONI L. A., BARBAS C. F., 3RD, COLLET T. A., LERNER R. A. AND KANG A. S. (1992). In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proceedings of the National Academy of Sciences of the USA, 89, 3576-80.
52. HANKE T., SZAWLOWSKI P. AND RANDALL R. E. (1992). Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. Journal of General Virology, 73 (Pt 3), 653-60.
53. HARRIS M. (2004). Monoclonal antibodies as therapeutic agents for cancer. The Lancet: Oncology, 5, 292-302.
54. HOLLIGER P. AND RIECHMANN L. (1997). A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd. Structure, 5, 265-75.
55. HOLT L. J., ENEVER C., DE WILDT R. M. AND TOMLINSON I. M. (2000). The use of recombinant antibodies in proteomics. Current Opinion in Biotechnology, 11, 445-9.
56. HOOGENBOOM H. R., GRIFFITHS A. D., JOHNSON K. S., CHISWELL D. J., HUDSON P. AND WINTER G. (1991). Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Research, 19, 4133-7.
57. HUDSON P. J. AND SOURIAU C. (2003). Engineered antibodies. Nature Medicine, 9, 129-34.
58. HULS G., GESTEL D., VAN DER LINDEN J., MORET E. AND LOGTENBERG T. (2001). Tumor cell killing by in vitro affinity-matured recombinant human monoclonal antibodies. Cancer Immunology, Immunotherapy, 50, 163-71.
59. IRVING R. A., KORTT A. A. AND HUDSON P. J. (1996). Affinity maturation of recombinant antibodies using E. coli mutator cells. Immunotechnology, 2, 127-43.
60. JOSTOCK T., VANHOVE M., BREPOELS E., VAN GOOL R., DAUKANDT M., WEHNERT A., VAN HEGELSOM R., DRANSFIELD D., SEXTON D., DEVLIN M., LEY A. AND MULLBERG J. (2004). Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries. Journal of Immunological Methods, 289, 65-80.
61. KANG A. S., BARBAS C. F., JANDA K. D., BENKOVIC S. J. AND LERNER R. A. (1991). Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proceedings of the National Academy of Sciences of the USA, 88, 4363-6.
62. KIM S. J., JANG M. H., STAPLETON J. T., YOON S. O., KIM K. S., JEON E. S. AND HONG H. J. (2004). Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display. Virology, 318, 598-607.
63. KOHLER G. AND MILSTEIN C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-7.
64. KRAMER R. A., COX F., VAN DER HORST M., VAN DER OUDENRIJN S., RES P. C., BIA J., LOGTENBERG T. AND DE KRUIF J. (2003). A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant protein. Nucleic Acids Research, 31, e59.
65. KREBS B., RAUCHENBERGER R., REIFFERT S., ROTHE C., TESAR M., THOMASSEN E., CAO M., DREIER T., FISCHER D., HOSS A., INGE L., KNAPPIK A., MARGET M., PACK P., MENG X. Q., SCHIER R., SOHLEMANN P., WINTER J., WOLLE J. AND KRETZSCHMAR T. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods, 254, 67-84.
66. KRETZSCHMAR T. AND GEISER M. (1995). Evaluation of antibodies fused to minor coat protein III and major coat protein VIII of bacteriophage M13. Gene, 155, 61-5.
67. KRETZSCHMAR T. AND VON RUDEN T. (2002). Antibody discovery: phage display. Current Opinion in Biotechnology, 13, 598-602.
68. KUHNE S. A., HAWES W. S., LA RAGIONE R. M., WOODWARD M. J., WHITELAM G. C. AND GOUGH K. C. (2004). Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7. Journal of Clinical Microbiology, 42, 2966-76.
69. LAH M., GOLDSTRAW A., WHITE J. F., DOLEZAL O., MALBY R. AND HUDSON P. J. (1994). Phage surface presentation and secretion of antibody fragments using an adaptable phagemid vector. Human Antibodies, Hybridomas, 5, 48-56.
70. LEE L. S., CONOVER C., SHI C., WHITLOW M. AND FILPULA D. (1999). Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. Bioconjugate Chemistry, 10, 973-81.
71. LEONG S. R., DEFORCE L., PRESTA L., GONZALEZ T., FAN A., REICHERT M., CHUNTHARAPAI A., KIM K. J., TUMAS D. B., LEE W. P., GRIBLING P., SNEDECOR B., CHEN H., HSEI V., SCHOENHOFF M., HALE V., DEVENEY J., KOUMENIS I., SHAHROKH Z., MCKAY P., GALAN W., WAGNER B., NARINDRAY D., HEBERT C. AND ZAPATA G. (2001). Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation. Cytokine, 16, 106-19.
72. LIANG M., DUBEL S., LI D., QUEITSCH I., LI W. AND BAUTZ E. K. (2001). Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. Journal of Immunological Methods, 247, 119-30.
73. LINDEROTH N. A., SIMON M. N. AND RUSSEL M. (1997). The filamentous phage pIV multimer visualized by scanning transmission electron microscopy. Science, 278, 1635-8.
74. LINDNER P., BAUER K., KREBBER A., NIEBA L., KREMMER E., KREBBER C., HONEGGER A., KLINGER B., MOCIKAT R. AND PLUCKTHUN A. (1997). Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. Biotechniques, 22, 140-9.
75. LLORENTE M., SANCHEZ-PALOMINO S., MANES S., LUCAS P., KREMER L., DE ALBORAN I. M., TORAN J. L., ALCAMI J., DEL REAL G. AND MARTINEZ A. C. (1999). Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes. Scandinavian Journal of Immunology, 50, 270-9.
76. LOW N. M., HOLLIGER P. H. AND WINTER G. (1996). Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. Journal of Molecular Biology, 260, 359-68.
77. LUBKOWSKI J., HENNECKE F., PLUCKTHUN A. AND WLODAWER A. (1998). The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p. Nature Structure and Molecular Biology, 5, 140-7.
78. MANCINI N., CANDUCCI F., CARLETTI S., BERARDINELLI E., SERAFINI G., GRIECO A., PEROTTI M., MALCANGI G., DANIELI M. G., VARALDO P. E., CLEMENTI M. AND BURIONI R. (2003). Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. Journal of Biological Regulators and Homeostatic Agents, 17, 183-7.
79. MAO S., GAO C., LO C. H., WIRSCHING P., WONG C. H. AND JANDA K. D. (1999). Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proceedings of the National Academy of Sciences of the USA, 96, 6953-8.
80. MARCIANO D. K., RUSSEL M. AND SIMON S. M. (1999). An aqueous channel for filamentous phage export. Science, 284, 1516-9.
81. MARKS J. D., HOOGENBOOM H. R., BONNERT T. P., MCCAFFERTY J., GRIFFITHS A. D. AND WINTER G. (1991). By-passing immunization. Human antibodies from V-gene libraries displayed on phage. Journal of Molecular Biology, 222, 581-97.
82. MARUYAMA T., PARREN P. W., SANCHEZ A., RENSINK I., RODRIGUEZ L. L., KHAN A. S., PETERS C. J. AND BURTON D. R. (1999). Recombinant human monoclonal antibodies to Ebola virus. Journal of Infectious Diseases, 179, Suppl 1, S235-9.
83. MARUYAMA T., SAITO I., HAYASHI Y., KOMPFNER E., FOX R. I., BURTON D. R. AND DITZEL H. J. (2004). Molecular analysis of the human autoantibody response to alpha-fodrin in Sjogren's syndrome reveals novel apoptosis-induced specificity. American Journal of Pathology, 165, 53-61.
84. MCCAFFERTY J., GRIFFITHS A. D., WINTER G. AND CHISWELL D. J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature, 348, 552-4.
85. NISSIM A., HOOGENBOOM H. R., TOMLINSON I. M., FLYNN G., MIDGLEY C., LANE D. AND WINTER G. (1994). Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO Journal, 13, 692-8.
86. NORDERHAUG L., OLAFSEN T., MICHAELSEN T. E. AND SANDLIE I. (1997). Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. Journal of Immunological Methods, 204, 77-87.
87. PARMLEY S. F. AND SMITH G. P. (1988). Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene, 73, 305-18.
88. PETRENKO V. A., SMITH G. P., GONG X. AND QUINN T. (1996). A library of organic landscapes on filamentous phage. Protein Engineering, 9, 797-801.
89. PLAISANT P., BURIONI R., MANZIN A., SOLFOROSI L., CANDELA M., GABRIELLI A., FADDA G. AND CLEMENTI M. (1997). Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors. Research in Virology, 148, 165-9.
90. PROULX C., BOYER L., ST-AMOUR I., BAZIN R. AND LEMIEUX R. (2002). Higher affinity human D MoAb prepared by light-chain shuffling and selected by phage display. Transfusion, 42, 59-65.
91. RAATS J. M., WIJNEN E. M., PRUIJN G. J., VAN DEN HOOGEN F. H. AND VAN VENROOIJ W. J. (2003). Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. Journal of Rheumatology, 30, 1696-711.
92. RADER C. AND BARBAS C. F., 3RD (1997). Phage display of combinatorial antibody libraries. Current Opinion in Biotechnology, 8, 503-8.
93. RAKONJAC J., JOVANOVIC G. AND MODEL P. (1997). Filamentous phage infection-mediated gene expression: construction and propagation of the gIII deletion mutant helper phage R408d3. Gene, 198, 99-103.
94. REICHE N., JUNG A., BRABLETZ T., VATER T., KIRCHNER T. AND FALLER G. (2002). Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens. Infection and Immunity, 70, 4158-64.
95. REICHERT J. M. (2001). Monoclonal antibodies in the clinic. Nature Biotechnology, 19, 819-22.
96. RHYNER C., WEICHEL M., HUBNER P., ACHATZ G., BLASER K. AND CRAMERI R. (2003). Phage display of human antibodies from a patient suffering from coeliac disease and selection of isotype-specific scFv against gliadin. Immunology, 110, 269-74.
97. ROARK J. H., BUSSEL J. B., CINES D. B. AND SIEGEL D. L. (2002). Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood, 100, 1388-98.
98. RONDOT S., KOCH J., BREITLING F. AND DUBEL S. (2001). A helper phage to improve single-chain antibody presentation in phage display. Nature Biotechnology, 19, 75-8.
99. ROOVERS R. C., VAN DER LINDEN E., DE BRUINE A. P., ARENDS J. W. AND HOOGENBOOM H. R. (2001). Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma. European Journal of Cancer, 37, 542-9.
100. Ross J. S., GRAY K., GRAY G. S., WORLAND P. J. AND ROLFE M. (2003). Anticancer antibodies. American Journal of Clinical Pathology, 119, 472-85.
101. SANZ L., BLANCO B. AND ALVAREZ-VALLINA L. (2004). Antibodies and gene therapy: teaching old 'magic bullets' new tricks. Trends in Immunology, 25, 85-91.
102. SBLATTERO D. AND BRADBURY A. (2000). Exploiting recombination in single bacteria to make large phage antibody libraries. Nature Biotechnology, 18, 75-80.
103. SCHIER R., BALINT R. F., MCCALL A., APELL G., LARRICK J. W. AND MARKS J. D. (1996a). Identification of functional and structural amino-acid residues by parsimonious mutagenesis. Gene, 169, 147-55.
104. SCHIER R., BYE J., APELL G., MCCALL A., ADAMS G. P., MALMQVIST M., WEINER L. M. AND MARKS J. D. (1996b). Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. Journal of Molecular Biology, 255, 28-43.
105. SCHIER R. AND MARKS J. D. (1996). Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. Human Antibodies, Hybridomas, 7, 97-105.
106. SCHIER R., MCCALL A., ADAMS G. P., MARSHALL K. W., MERRITT H., YIM M., CRAWFORD R. S., WEINER L. M., MARKS C. AND MARKS J. D. (1996c). Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. Journal of Molecular Biology, 263, 551-67.
107. SCOTT J. K. AND SMITH G. P. (1990). Searching for peptide ligands with an epitope library. Science, 249, 386-90.
108. SMITH G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315-7.
109. SOLTES G., BARKER H., MARMAI K., PUN E., YUEN A. AND WIERSMA E. J. (2003). A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions. Journal of Immunological Methods, 274, 233-44.
110. SUZUKI M., KATSUBE Y., SUZUKI H., TAKEMURA H. AND SUMIDA T. (1999). Cloning and functional analysis of anti-double strand DNA IgG autoantibodies using the phage-display method. International Journal of Molecular Medicine, 3, 385-90.
111. Thompson J. E., Vaughan T. J., Williams A. J., Wilton J., Johnson K. S., Bacon L., Green J. A., Field R., Ruddock S., Martins M., Pope A. R., Tempest P. R. And Jackson R. H. (1999). A fully human antibody neutralising biologically active human TGFbeta2 for use in therapy. Journal of Immunological Methods, 227, 17-29.
112. TRAGGIAI E., BECKER S., SUBBARAO K., KOLESNIKOVA L., UEMATSU Y., GISMONDO M. R., MURPHY B. R., RAPPUOLI R. AND LANZAVECCHIA A. (2004). An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nature Medicine, 10, 871-5.
113. TRIKHA M., YAN L. AND NAKADA M. T. (2002). Monoclonal antibodies as therapeutics in oncology. Current Opinion in Biotechnology, 13, 609-14.
114. VAN DIJK M. A. AND VAN DE WINKEL J. G. (2001). Human antibodies as next generation therapeutics. Current Opinion in Chemical Biology, 5, 368-74.
115. VAUGHAN T. J., WILLIAMS A. J., PRITCHARD K., OSBOURN J. K., POPE A. R., EARNSHAW J. C., MCCAFFERTY J., HODITS R. A., WILTON J. AND JOHNSON K. S. (1996). Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnology, 14, 309-14.
116. WARD R. L., CLARK M. A., LEES J. AND HAWKINS N. J. (1996). Retrieval of human antibodies from phage-display libraries using enzymatic cleavage. Journal of Immunological Methods, 189, 73-82.
117. WEBSTER R. (2001). Filamentous Phage Biology. In: Phage Display: A Laboratory Manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press.
118. WILLIAMSON R. A., BURIONI R., SANNA P. P., PARTRIDGE L. J., BARBAS III C. F. AND BURTON D. R. (1993). Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proceedings of the National Academy of Sciences of the U S A, 90, 4141-5.
119. WRIGHTON N. C., FARRELL F. X., CHANG R., KASHYAP A. K., BARBONE F. P., MULCAHY L. S., JOHNSON D. L., BARRETT R. W., JOLLIFFE L. K. AND DOWER W. J. (1996). Small peptides as potent mimetics of the protein hormone erythropoietin. Science, 273, 458-64.
120. Wu B. P., XIAO B., WAN T. M., ZHANG Y. L., ZHANG Z. S., ZHOU D. Y., LAI Z. S. AND GAO C. F. (2001). Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer. World Journal of Gastroenterology, 7, 811-5.
121. XU M. Y., XU X. H., CHEN G. Z., DENG X. L., LI J., YU X. J. AND CHEN M. Z. (2004). Production of a human single-chain variable fragment antibody against esophageal carcinoma. World Journal of Gastroenterology, 10, 2619-23.
122. YANG W. P., GREEN K., PINZ-SWEENEY S., BRIONES A. T., BURTON D. R. AND BARBAS III C. F. (1995). CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. Journal of Molecular Biology, 254, 392-403.
123. ZHANG M. Y., XIAO X., SIDOROV I. A., CHOUDHRY V., CHAM F., ZHANG P. F., BOUMA P., ZWICK M., CHOUDHARY A., MONTEFIORI D. C., BRODER C. C., BURTON D. R., QUINNAN G. V. JR., AND DIMITROV D. S. (2004). Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody, Journal of Virology, 78, 9233-42.
124. ZHOU B., WIRSCHING P. AND JANDA K. D. (2002). Human antibodies against spores of the genus Bacillus: a model study for detection of and protection against anthrax and the bioterrorist threat. Proceedings of the National Academy of Sciences of the USA, 99, 5241-6.
125. ZWICK M. B., KELLEHER R., JENSEN R., LABRIJN A. F., WANG M., QUINNAN G. V., JR., PARREN P. W. AND BURTON D. R. (2003). A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. Journal of Virology, 77, 6965-78.